As of 3:28:28 PM EST. Market Open.
Breakdown
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Assets
235,404.00
183,202.00
203,880.00
272,013.00
Total Liabilities Net Minority Interest
28,822.00
22,177.00
18,787.00
14,820.00
Total Equity Gross Minority Interest
206,582.00
161,025.00
185,093.00
257,193.00
Total Capitalization
206,582.00
161,025.00
185,093.00
257,193.00
Common Stock Equity
206,582.00
161,025.00
185,093.00
257,193.00
Capital Lease Obligations
7,317.00
8,232.00
8,188.00
5,909.00
Net Tangible Assets
206,582.00
161,025.00
185,093.00
257,193.00
Working Capital
202,883.00
157,294.00
182,071.00
254,490.00
Invested Capital
206,582.00
161,025.00
185,093.00
257,193.00
Tangible Book Value
206,582.00
161,025.00
185,093.00
257,193.00
Total Debt
7,317.00
8,232.00
8,188.00
5,909.00
Share Issued
42,521.98
34,171.14
24,550.75
24,422.53
Ordinary Shares Number
42,521.98
34,171.14
24,550.75
24,422.53
4/30/2021 - 4/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
18.30
-0.54%
PTGX Protagonist Therapeutics, Inc.
41.32
+0.58%
DNTH Dianthus Therapeutics, Inc.
23.95
+0.59%
CLYM Climb Bio Inc
2.4200
-6.92%
ATXS Astria Therapeutics, Inc.
9.61
+0.89%
ORKA Oruka Therapeutics, Inc.
21.82
-0.55%
VRDN Viridian Therapeutics, Inc.
22.07
+23.64%
TRML Tourmaline Bio, Inc.
22.06
+1.15%
ABVX ABIVAX Société Anonyme
7.97
+12.10%
SLN Silence Therapeutics plc
6.73
+4.40%